Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 RAYMED LABS   ACTAVIS
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
ACTAVIS
Dec-18
RAYMED LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs216,126-   
Low Rs110,818-   
Sales per share (Unadj.) Rs03,955.8-  
Earnings per share (Unadj.) Rs-0.4-1,274.2-  
Cash flow per share (Unadj.) Rs-0.4416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-5.416,315.7-  
Shares outstanding (eoy) m4.27332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x03.4-  
Avg P/E ratio x-4.4-10.6 41.7%  
P/CF ratio (eoy) x-4.632.3 -14.1%  
Price / Book Value ratio x-0.30.8 -39.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m84,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m00-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m01,315,689 0.0%  
Other income Rs m025,160 0.0%   
Total revenues Rs m01,340,849 0.0%   
Gross profit Rs m-234,478 -0.0%  
Depreciation Rs m0562,428 0.0%   
Interest Rs m075,923 0.0%   
Profit before tax Rs m-2-578,713 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m0-7,334 -0.0%   
Profit after tax Rs m-2-423,784 0.0%  
Gross profit margin %02.6- 
Effective tax rate %01.3 -0.0%   
Net profit margin %0-32.2- 
BALANCE SHEET DATA
Current assets Rs m0539,627 0.0%   
Current liabilities Rs m1477,372 0.0%   
Net working cap to sales %04.7- 
Current ratio x0.11.1 4.9%  
Inventory Days Days020- 
Debtors Days Days066- 
Net fixed assets Rs m2148,929 0.0%   
Share capital Rs m430-   
"Free" reserves Rs m-660-   
Net worth Rs m-235,426,601 -0.0%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m28,483,012 0.0%  
Interest coverage x0-6.6-  
Debt to equity ratio x00.4 -0.0%  
Sales to assets ratio x00.2 0.0%   
Return on assets %-109.5-4.1 2,669.8%  
Return on equity %7.4-7.8 -94.9%  
Return on capital %7.4-4.8 -153.0%  
Exports to sales %00-  
Imports to sales %00-  
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-2470,046 -0.0%  
From Investments Rs m2258,229 0.0%  
From Financial Activity Rs mNA-806,740 -0.0%  
Net Cashflow Rs m0-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare RAYMED LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare RAYMED LABS With: UNICHEM LAB  SYNCOM HEALTHCARE  MAKERS LAB.  SUPRIYA LIFESCIENCE   ALEMBIC  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.